Congressional trades by ticker
NVS congressional trades
- Verified rows
- 11
- Filers
- 2
- Purchases
- 5
- Latest trade
- 2025-10-31
Verified NVS House disclosures
Parsed from official House Clerk periodic transaction reports. This snapshot contains 5 purchases and 6 sales. Reported owners: Spouse, Self. Transaction dates run from 2025-03-24 to 2025-10-31.
| Politician | Trade date | Asset | Type | Owner | Amount | Filing |
|---|---|---|---|---|---|---|
| Lisa McClain | Novartis AG Common Stock | Sale | Spouse | $1,001 - $15,000 | #20033446 Filed 2025-11-21 | |
| Lisa McClain | Novartis AG Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20033446 Filed 2025-11-21 | |
| Lisa McClain | Novartis AG Common Stock | Sale | Spouse | $1,001 - $15,000 | #20033446 Filed 2025-11-21 | |
| Lisa McClain | Novartis AG Common Stock | Sale | Spouse | $1,001 - $15,000 | #20032129 Filed 2025-10-22 | |
| Lisa McClain | Novartis AG Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20032129 Filed 2025-10-22 | |
| Lisa McClain | Novartis AG Common Stock | Sale | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| Lisa McClain | Novartis AG Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| Lisa McClain | Novartis AG Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| Lisa McClain | Novartis AG Common Stock | Sale | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| Lisa McClain | Novartis AG Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| George Whitesides | stock, company-specific holdings into passive ETFs and mutual funds, per best practices. C: To avoid any possible conflicts of interest with my future Congressional work, I’m transitioning my single stock, company-specific holdings into passive ETFs and mutual funds, per best practices. Novartis AG Common Stock | Sale | Self | $100,001 - $250,000 | #20027982 Filed 2025-04-23 |
A filing can describe the member, a spouse, a dependent, or a joint asset. Amounts are statutory ranges, not execution prices. See how to read congressional stock-trade disclosures before treating a delayed row as a trading signal.
The filing is free
Keep the NVS range and owner as filed. Membership adds the investment view around the money, not a list to copy.
Related research
NVS congressional trades — FAQ
Who in Congress traded NVS?
House Clerk periodic reports for 2025 and 2026 contain 11 verified NVS rows from 2 members: George Whitesides and Lisa McClain. Image-only filings are excluded, and this is not a live brokerage statement.
Does this page show current NVS holdings?
No. STOCK Act filings disclose reportable transactions after the fact, usually within 45 days, as amount ranges and owners. They do not prove a current position, an exact share count, or why the trade happened.
Why are NVS amounts shown as ranges?
House periodic transaction reports use statutory value bands such as $1,001 - $15,000; $100,001 - $250,000. Yield Theory keeps those ranges instead of inventing a midpoint, exact trade size, or return.
How complete is NVS congressional-trade coverage?
This snapshot covers every machine-readable House periodic transaction report for 2025 and 2026 (142 members). Image-only filings and Senate eFD filings are not included, so missing rows are not proof that no other lawmaker traded NVS.
Yield Theory is not affiliated with any elected official. This page uses the 2025–2026 House Clerk periodic report snapshot generated 2026-09-20. It is not a complete lifetime portfolio, a performance track record, or investment advice.
A disclosure is not a thesis.
This page shows who reported NVS and in what range. Membership is the monthly sourced call, plus a five-minute check when the evidence moves. $15/month or $150/year.
$15/mo or $150/yr · cancel future renewals anytime · sources included